This program project is focused on the major medical complications of genital HSV infection. The first Project evaluates the interaction between HSV and HIV-1. Studies to evaluate if abrogation of HSV shedding by acyclovir reduces HIV 1 replication on mucosal surfaces and lymphoid tissue are described. HIV-1 quasispecies evolution and measurement of reservoirs of HIV-1 in cells and lymphoid tissue will be performed. Studies to determine if HSV-2 infection increases HIV-1 transmission among HIV-1 discordant couples and whether acyclovir reduces HIV-1 acquisition among HSV-2 seropositive persons are also proposed. The second Project, Maternal Morbidity and Complications of Genital Herpes is directed at determining if serological screening and counseling will reduce high-risk sexual behavior among pregnant women at risk of acquiring genital herpes. Clinical trials are proposed to develop a short course chemoprophylaxis regimen with oral and IV acyclovir analogous to Group B strep prevention.
Specific Aim 3 describes the development of a rapid assay to detect HSV DNA by PCR at labor and delivery. A cost utility analysis on strategies to improve the management of the HSV-2 seropositive pregnant women is also proposed. The third Project Lymphocyte Trafficking of Genital HSV-2 Infections. HSV specific CD8 T -cells of chronically infected persons with HSV-2 express the homing molecule CLA and this molecule is acquired during the course of infection. Studies to determine the role of CLA and other surface homing molecules on HSV specific T cells or effectors function are described. The four cores associated with the PO-1 are a Clinical Core directed at enrolling patients into the proposed trials, a Laboratory Core which performs all the HSV and HIV serological assays, HSV PCR and HIV molecular assays utilized in these studies. A Statistical Core is devoted to study-design, data management and analyses and a small Administrative Core. Collaborations with investigators in Peru, Zambia, Zimbabwe, Cameroon and Canada are proposed.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI030731-16
Application #
7054671
Study Section
Microbiology and Infectious Diseases B Subcommittee (MID)
Program Officer
David, Hagit S
Project Start
1991-04-01
Project End
2008-03-31
Budget Start
2006-04-01
Budget End
2007-03-31
Support Year
16
Fiscal Year
2006
Total Cost
$1,618,410
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Schiffer, Joshua T; Swan, Dave A; Roychoudhury, Pavitra et al. (2018) A Fixed Spatial Structure of CD8+ T Cells in Tissue during Chronic HSV-2 Infection. J Immunol 201:1522-1535
Traidl, Stephan; Kienlin, Petra; Begemann, Gabriele et al. (2018) Patients with atopic dermatitis and history of eczema herpeticum elicit herpes simplex virus-specific type 2 immune responses. J Allergy Clin Immunol 141:1144-1147.e5
Ramchandani, Meena; Selke, Stacy; Magaret, Amalia et al. (2018) Prospective cohort study showing persistent HSV-2 shedding in women with genital herpes 2 years after acquisition. Sex Transm Infect 94:568-570
Boucoiran, Isabelle; Mayer, Bryan T; Krantz, Elizabeth M et al. (2018) Nonprimary Maternal Cytomegalovirus Infection After Viral Shedding in Infants. Pediatr Infect Dis J 37:627-631
Kleinstein, Sarah E; Shea, Patrick R; Allen, Andrew S et al. (2018) Genome-wide association study (GWAS) of human host factors influencing viral severity of herpes simplex virus type 2 (HSV-2). Genes Immun :
Ott, Mariliis; Jing, Lichen; Lorenzo, Lazaro et al. (2017) T-cell Responses to HSV-1 in Persons Who Have Survived Childhood Herpes Simplex Encephalitis. Pediatr Infect Dis J 36:741-744
Bender Ignacio, Rachel A; Ramchandani, Meena S; Laing, Kerry J et al. (2017) T Cell Immunity to Varicella-Zoster Virus in the Setting of Advanced HIV and Multiple Varicella-Zoster Virus Recurrences. Viral Immunol 30:77-80
Koelle, David M; Norberg, Peter; Fitzgibbon, Matthew P et al. (2017) Worldwide circulation of HSV-2?×?HSV-1 recombinant strains. Sci Rep 7:44084
Looker, Katharine J; Elmes, Jocelyn A R; Gottlieb, Sami L et al. (2017) Effect of HSV-2 infection on subsequent HIV acquisition: an updated systematic review and meta-analysis. Lancet Infect Dis 17:1303-1316
Gottlieb, Sami L; Giersing, Birgitte; Boily, Marie-Claude et al. (2017) Modelling efforts needed to advance herpes simplex virus (HSV) vaccine development: Key findings from the World Health Organization Consultation on HSV Vaccine Impact Modelling. Vaccine :

Showing the most recent 10 out of 345 publications